Gisèle Deblandre
Geen lopende functies
Profiel
Gisèle Deblandre worked as a Director-Development at Celyad Oncology SA, and as a Principal at Metabolic Research, Inc. and Biowind Sp zoo.
She holds a doctorate degree from Université Libre de Bruxelles.
Eerdere bekende functies van Gisèle Deblandre
| Bedrijven | Functie | Einde |
|---|---|---|
Biowind Sp zoo
 Biowind Sp zoo Electric UtilitiesUtilities Part of KGHM Polska Miedz SA, Biowind Sp zoo is a Polish company that produces wind power. The company is based in Gdansk, Poland. Biowind was acquired by Energetyka Sp zoo on January 06, 2009 for $0.15 million. | Corporate Officer/Principal | - |
Metabolic Research, Inc.
 Metabolic Research, Inc. Pharmaceuticals: MajorHealth Technology Metabolic Research, Inc. is a biotechnology company that produces and markets proprietary nutraceuticals. The company is developing a new form of pharmaceutical-grade and non-synthetic pharmaceutical which is aimed to safely and effectively treat arthritis, heart disease and metabolic and inflammatory diseases. Metabolic Research was founded on October 7, 1996 and is headquartered in Las Vegas, NV. | Corporate Officer/Principal | - |
| CELYAD ONCOLOGY SA | Corporate Officer/Principal | - |
Opleiding van Gisèle Deblandre
| Université Libre de Bruxelles | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CELYAD ONCOLOGY SA | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Biowind Sp zoo
Biowind Sp zoo Electric UtilitiesUtilities Part of KGHM Polska Miedz SA, Biowind Sp zoo is a Polish company that produces wind power. The company is based in Gdansk, Poland. Biowind was acquired by Energetyka Sp zoo on January 06, 2009 for $0.15 million. | Utilities |
Metabolic Research, Inc.
Metabolic Research, Inc. Pharmaceuticals: MajorHealth Technology Metabolic Research, Inc. is a biotechnology company that produces and markets proprietary nutraceuticals. The company is developing a new form of pharmaceutical-grade and non-synthetic pharmaceutical which is aimed to safely and effectively treat arthritis, heart disease and metabolic and inflammatory diseases. Metabolic Research was founded on October 7, 1996 and is headquartered in Las Vegas, NV. | Health Technology |
